Showing results (101-110 of 1,683) with videos related to

Sort By:
Pageof 169
Archives of General Psychiatry|October 24, 1997
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findingsS Nyberg, L Farde, C Halldin
Journal of the European Academy of Dermatology and Venereology : JEADV|September 14, 2011
Teaching peripheral nerve blocks for the head and neck area to dermatologistsJ Paoli, C Halldin, C Sandberg
Nuclear Medicine and Biology|May 1, 1994
Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomographyC Halldin, T Högberg, L Farde
Psychiatry Research|October 7, 1996
Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patientsS Nyberg, L Farde, C Halldin
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 1999
Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization techniqueH Ito, C Halldin, L Farde
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 1, 1997
A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjectsS Nyberg, L Farde, C Halldin
The Journal of Comparative Neurology|July 15, 1999
Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization studyY L Hurd, E Keller, P Sotonyi, et al.
Psychiatry Research|May 1, 1980
Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin reuptake inhibitor (zimelidine) in chronic pain patientsF Johansson, L von Knorring, G Sedvall, et al.
The European Journal of Neuroscience|June 1, 1997
Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatumL Caberlotto, K Fuxe, G Sedvall, et al.
Acta Psychiatrica Scandinavica|August 1, 1977
Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patientsB Wode-Helgodt, B Fyrö, B Gullberg, et al.
Pageof 169